BMJ Best Practice

参考文献

关键文献

Bondi EE, Margolis DJ, Lazarus ZS. Panniculitis. In: Freedberg I, Eisen A, Wolff K, et al, eds. Fitzpatrick's dermatology in general medicine. 5th ed. New York, NY: McGraw-Hill; 1999: 1284-1286.

Requena L, Requena C. Erythema nodosum (review). Dermatol Online J. 2002;8:4.

Benamour S, Naji T, Alaoui F, et al. Neurological involvement in Behcet's disease: 154 cases from a cohort of 925 patients and review of the literature. Rev Neurol (Paris). 2006;162:1084-1090.

Friedman ES, LaNatra N, Stiller MJ. NSAIDs in dermatologic therapy: review and preview. J Cutan Med Surg. 2002;6:449-459.

Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol. 2000;43:691-697.

Schultz E, Whiting D. Treatment of erythema nodosum and nodular vasculitis with potassium iodides. Br J Dermatol. 1976;94:75-78.

参考文章

1.  Bondi EE, Margolis DJ, Lazarus ZS. Panniculitis. In: Freedberg I, Eisen A, Wolff K, et al, eds. Fitzpatrick's dermatology in general medicine. 5th ed. New York, NY: McGraw-Hill; 1999: 1284-1286.

2.  Requena L, Requena C. Erythema nodosum (review). Dermatol Online J. 2002;8:4.

3.  Grunewald J, Eklund A. Sex-specific manifestations of Lofgren's syndrome. Am J Respir Crit Care Med. 2007;175:40-44.

4.  Benamour S, Naji T, Alaoui F, et al. Neurological involvement in Behcet's disease: 154 cases from a cohort of 925 patients and review of the literature. Rev Neurol (Paris). 2006;162:1084-1090.

5.  DiCaudo DJ. Coccidioidomycosis: a review and update. J Am Acad Dermatol. 2006;55:929-942.

6.  Jalava K, Hakkinen M, Valkonen M, et al. An outbreak of gastrointestinal illness and erythema nodosum from grated carrots contaminated with Yersinia pseudotuberculosis. J Infect Dis. 2006;194:1209-1216.

7.  Klusmann A, Magahed M, Kruse R, et al. Painful rash and swelling of the limbs after recurrent infections in a teenager: polyarteritis nodosa. Acta Paediatr. 2006;95:1317-1320.

8.  Friedman ES, LaNatra N, Stiller MJ. NSAIDs in dermatologic therapy: review and preview. J Cutan Med Surg. 2002;6:449-459.

9.  Abenavoli L, Proietti I, Leggio L, et al. Cutaneous manifestations in celiac disease. World J Gastroenterol. 2006;12:843-852.

10.  Trost L, McDonnell J. Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J. 2005;81:580-585.

11.  Pettersson T. Sarcoid and erythema nodosum arthropathies. Best Pract Res Clin Rheumatol. 2000;14:461-476.

12.  Velho P, Cintra M, Uthida-Tanaka A, et al. What do we (not) know about the human bartonelloses? Braz J Infect Dis. 2003;7:1-6.

13.  Thrash B, Patel M, Shah KR, et al. Cutaneous manifestations of gastrointestinal disease: part II. J Am Acad Dermatol. 2013;68:211.

14.  Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol. 2000;43:691-697.

15.  Schultz E, Whiting D. Treatment of erythema nodosum and nodular vasculitis with potassium iodides. Br J Dermatol. 1976;94:75-78.

16.  Van Veen NH, Lockwood DN, van Brakel WH, et al. Interventions for erythema nodosum leprosum. Cochrane Database Syst Rev. 2009;(3):CD006949.

17.  Wu JJ, Huang DP, Pang KR, et al. Thalidomide: dermatological indications, mechanisms of action and side-effects. Br J Dermatol. 2005;153:254-273.

18.  Verma KK, Srivastava P, Minza A, et al. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum. Lepr Rev. 2006;77:225-229.

19.  Meggitt SJ, Anstey AV, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011. Br J Dermatol. 2011;165:711-734.

使用此内容应接受我们的免责声明